BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, May 11, 2026
Home » Authors » Nuala Moran

Articles by Nuala Moran

Progress In Two Early Programs Gives Xenova Much-Needed Lift

April 23, 2003
By Nuala Moran

Celltech Poised To Acquire OGS After Other Parties Drop Interest

April 16, 2003
By Nuala Moran
LONDON - Oxford GlycoSciences plc succumbed to the hostile bid from Celltech plc that will lead to the breakup of the business, after failing to attract any better offers. (BioWorld International)
Read More

Proteome Sciences, IDEXX Enter Deal To Develop BSE Diagnostic

April 16, 2003
By Nuala Moran

MedPharma Looking To Go Public To Fund Sexual Dysfunction Drugs

April 16, 2003
By Nuala Moran

Oxxon Completes £15M Round To Fund Therapeutic Vaccines

April 16, 2003
By Nuala Moran

Proteome Sciences, IDEXX Enter Deal To Develop BSE Diagnostic

April 16, 2003
By Nuala Moran

MedPharma Looking To Go Public To Fund Sexual Dysfunction Drugs

April 16, 2003
By Nuala Moran

Celltech Poised To Acquire OGS After Other Parties Drop Interest

April 16, 2003
By Nuala Moran
LONDON - Oxford GlycoSciences plc succumbed to the hostile bid from Celltech plc that will lead to the breakup of the business, after failing to attract any better offers. (BioWorld International)
Read More

Oxxon Completes £15M Round To Fund Therapeutic Vaccines

April 16, 2003
By Nuala Moran

Celltech Gains Clear Advantage In Bid For Oxford GlycoSciences

April 14, 2003
By Nuala Moran
Previous 1 2 … 483 484 485 486 487 488 489 490 491 … 537 538 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 8, 2026.
  • Rendering of a key measles protein targeted by neutralizing human antibodies

    First measles treatment advances as vaccination rates drop

    BioWorld
    Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
  • Infensa Bioscience identifies new ASIC blockers

    BioWorld Science
    Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
  • Close up of bow of cruise ship

    Hantavirus is ‘sentinel’ more than acute pandemic threat

    BioWorld
    News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
  • Neurology illustration

    Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst

    BioWorld
    Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing